EHC - CIK 0000785161
The table below shows Encompass Health Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | - | - | - | $705.80M | $715.80M | $704.70M |
| Capital expenditure | - | - | - | $564.80M | $524.60M | $392.80M |
| Investing cash flow | -$764.60M | -$653.30M | -$602.80M | -$627.00M | -$666.30M | -$407.50M |
| Dividends paid | $71.10M | $62.80M | $60.40M | $99.00M | $112.20M |
Encompass Health Corp reported operating cash flow of $705.80M for fiscal year 2022. That is down 1.4% from $715.80M in fiscal 2021. Over the 10 fiscal years shown, operating cash flow grew from $470.30M (FY 2013) to $705.80M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $111.80M |
| Stock buybacks | $158.00M | $31.10M | $0.00 | $0.00 | $0.00 | $6.10M |
| Financing cash flow | -$431.20M | -$330.60M | -$197.20M | -$145.70M | -$240.10M | -$145.90M |